SG Americas Securities LLC cut its position in shares of Foundation Medicine, Inc. (NASDAQ:FMI) by 8.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,745 shares of the company’s stock after selling 424 shares during the quarter. SG Americas Securities LLC’s holdings in Foundation Medicine were worth $189,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. American International Group Inc. boosted its holdings in Foundation Medicine by 7.1% during the 1st quarter. American International Group Inc. now owns 8,287 shares of the company’s stock valued at $267,000 after acquiring an additional 549 shares during the period. Creative Planning boosted its holdings in Foundation Medicine by 15.3% during the 2nd quarter. Creative Planning now owns 5,075 shares of the company’s stock valued at $202,000 after acquiring an additional 675 shares during the period. Wells Fargo & Company MN boosted its holdings in Foundation Medicine by 7.0% during the 1st quarter. Wells Fargo & Company MN now owns 10,579 shares of the company’s stock valued at $341,000 after acquiring an additional 692 shares during the period. Whittier Trust Co. boosted its holdings in Foundation Medicine by 3.1% during the 2nd quarter. Whittier Trust Co. now owns 43,338 shares of the company’s stock valued at $1,723,000 after acquiring an additional 1,285 shares during the period. Finally, Teachers Advisors LLC boosted its holdings in Foundation Medicine by 5.7% during the 1st quarter. Teachers Advisors LLC now owns 24,387 shares of the company’s stock valued at $786,000 after acquiring an additional 1,316 shares during the period. Hedge funds and other institutional investors own 31.84% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “SG Americas Securities LLC Sells 424 Shares of Foundation Medicine, Inc. (FMI)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/21/sg-americas-securities-llc-sells-424-shares-of-foundation-medicine-inc-fmi.html.

Shares of Foundation Medicine, Inc. (FMI) opened at 39.05 on Thursday. The stock’s market cap is $1.41 billion. Foundation Medicine, Inc. has a 12-month low of $17.10 and a 12-month high of $43.15. The firm has a 50-day moving average price of $38.81 and a 200 day moving average price of $36.81.

Foundation Medicine (NASDAQ:FMI) last issued its quarterly earnings data on Tuesday, August 1st. The company reported ($1.24) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.08) by ($0.16). Foundation Medicine had a negative return on equity of 109.63% and a negative net margin of 131.79%. The company had revenue of $35.00 million for the quarter, compared to the consensus estimate of $34.94 million. During the same period in the previous year, the firm earned ($0.84) earnings per share. The company’s revenue was up 23.9% compared to the same quarter last year. Equities research analysts expect that Foundation Medicine, Inc. will post ($4.64) earnings per share for the current year.

Several equities research analysts recently weighed in on FMI shares. Zacks Investment Research upgraded Foundation Medicine from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. BidaskClub upgraded Foundation Medicine from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 24th. Finally, ValuEngine upgraded Foundation Medicine from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. Six research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $29.50.

In other news, CFO Jason Ryan sold 6,683 shares of the company’s stock in a transaction that occurred on Thursday, July 6th. The stock was sold at an average price of $38.84, for a total transaction of $259,567.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Krishna Yeshwant sold 4,800 shares of the company’s stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $40.01, for a total value of $192,048.00. Following the transaction, the director now directly owns 5,786 shares in the company, valued at approximately $231,497.86. The disclosure for this sale can be found here. Insiders have sold 182,552 shares of company stock worth $7,123,185 over the last three months. 2.70% of the stock is currently owned by insiders.

Foundation Medicine Profile

Foundation Medicine, Inc is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer.

Institutional Ownership by Quarter for Foundation Medicine (NASDAQ:FMI)

Receive News & Stock Ratings for Foundation Medicine Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foundation Medicine Inc. and related stocks with our FREE daily email newsletter.